202 related articles for article (PubMed ID: 31823682)
1. Advanced drug-delivery systems: mechanoresponsive nanoplatforms applicable in atherosclerosis management.
Nurhidayah D; Maruf A; Zhang X; Liao X; Wu W; Wang G
Nanomedicine (Lond); 2019 Dec; 14(23):3105-3122. PubMed ID: 31823682
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive approach of hybrid nanoplatforms in drug delivery and theranostics to combat cancer.
Thorat ND; Townley HE; Patil RM; Tofail SAM; Bauer J
Drug Discov Today; 2020 Jul; 25(7):1245-1252. PubMed ID: 32371139
[TBL] [Abstract][Full Text] [Related]
3. Reactive oxygen species responsive nanoplatforms as smart drug delivery systems for gastrointestinal tract targeting.
Bertoni S; Machness A; Tiboni M; Bártolo R; Santos HA
Biopolymers; 2020 Jan; 111(1):e23336. PubMed ID: 31724750
[TBL] [Abstract][Full Text] [Related]
4. Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics.
Zhang W; Liu M; Liu A; Zhai G
Curr Pharm Des; 2017; 23(23):3367-3382. PubMed ID: 27784244
[TBL] [Abstract][Full Text] [Related]
5. Recent Advances of Using Hybrid Nanocarriers in Remotely Controlled Therapeutic Delivery.
Li Z; Ye E; David ; Lakshminarayanan R; Loh XJ
Small; 2016 Sep; 12(35):4782-4806. PubMed ID: 27482950
[TBL] [Abstract][Full Text] [Related]
6. Recent Advances in pH-Sensitive Polymeric Nanoparticles for Smart Drug Delivery in Cancer Therapy.
Lim EK; Chung BH; Chung SJ
Curr Drug Targets; 2018 Feb; 19(4):300-317. PubMed ID: 27262486
[TBL] [Abstract][Full Text] [Related]
7. Mechanical Force-Triggered Drug Delivery.
Zhang Y; Yu J; Bomba HN; Zhu Y; Gu Z
Chem Rev; 2016 Oct; 116(19):12536-12563. PubMed ID: 27680291
[TBL] [Abstract][Full Text] [Related]
8. Mesoporous silica nanoparticles for stimuli-responsive controlled drug delivery: advances, challenges, and outlook.
Song Y; Li Y; Xu Q; Liu Z
Int J Nanomedicine; 2017; 12():87-110. PubMed ID: 28053526
[TBL] [Abstract][Full Text] [Related]
9. Novel magneto-responsive nanoplatforms based on MnFe
Jardim KV; Palomec-Garfias AF; Andrade BYG; Chaker JA; Báo SN; Márquez-Beltrán C; Moya SE; Parize AL; Sousa MH
Mater Sci Eng C Mater Biol Appl; 2018 Nov; 92():184-195. PubMed ID: 30184741
[TBL] [Abstract][Full Text] [Related]
10. Stepwise pH-responsive nanoparticles for enhanced cellular uptake and on-demand intracellular release of doxorubicin.
Chen WL; Li F; Tang Y; Yang SD; Li JZ; Yuan ZQ; Liu Y; Zhou XF; Liu C; Zhang XN
Int J Nanomedicine; 2017; 12():4241-4256. PubMed ID: 28652730
[TBL] [Abstract][Full Text] [Related]
11. Stimulus Sensitive Smart Nanoplatforms: An Emerging Paradigm for the Treatment of Skin Diseases.
Divya ; Kaur G
Curr Drug Deliv; 2019; 16(4):295-311. PubMed ID: 30674258
[TBL] [Abstract][Full Text] [Related]
12. Triple stimuli-responsive keratin nanoparticles as carriers for drug and potential nitric oxide release.
Li Y; Lin J; Zhi X; Li P; Jiang X; Yuan J
Mater Sci Eng C Mater Biol Appl; 2018 Oct; 91():606-614. PubMed ID: 30033293
[TBL] [Abstract][Full Text] [Related]
13. Lipid-based drug delivery systems for cancer treatment.
Arias JL; Clares B; Morales ME; Gallardo V; Ruiz MA
Curr Drug Targets; 2011 Jul; 12(8):1151-65. PubMed ID: 21443475
[TBL] [Abstract][Full Text] [Related]
14. pH-sensitive Au-BSA-DOX-FA nanocomposites for combined CT imaging and targeted drug delivery.
Huang H; Yang DP; Liu M; Wang X; Zhang Z; Zhou G; Liu W; Cao Y; Zhang WJ; Wang X
Int J Nanomedicine; 2017; 12():2829-2843. PubMed ID: 28435261
[TBL] [Abstract][Full Text] [Related]
15. Neodymium doped hydroxyapatite theranostic nanoplatforms for colon specific drug delivery applications.
Victor SP; Paul W; Vineeth VM; Komeri R; Jayabalan M; Sharma CP
Colloids Surf B Biointerfaces; 2016 Sep; 145():539-547. PubMed ID: 27281239
[TBL] [Abstract][Full Text] [Related]
16. Acid-triggered echogenic nanoparticles for contrast-enhanced ultrasound imaging and therapy of acute liver failure.
Go Y; Lee H; Jeong L; Sun S; Hong E; Jung E; Ko C; Noh J; Park S; Lee M; Song C; Lee D
Biomaterials; 2018 Dec; 186():22-30. PubMed ID: 30278343
[TBL] [Abstract][Full Text] [Related]
17. Schiff base interaction tuned mesoporous organosilica nanoplatforms with pH-responsive degradability for efficient anti-cancer drug delivery in vivo.
Liu L; Kong C; Huo M; Liu C; Peng L; Zhao T; Wei Y; Qian F; Yuan J
Chem Commun (Camb); 2018 Aug; 54(66):9190-9193. PubMed ID: 30062359
[TBL] [Abstract][Full Text] [Related]
18. Preparation of collagen peptide functionalized chitosan nanoparticles by ionic gelation method: An effective carrier system for encapsulation and release of doxorubicin for cancer drug delivery.
Anandhakumar S; Krishnamoorthy G; Ramkumar KM; Raichur AM
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):378-385. PubMed ID: 27770906
[TBL] [Abstract][Full Text] [Related]
19. Stimulus-Responsive Drug Delivery Nanoplatforms for Osteoarthritis Therapy.
Jiang Q; Zhang S
Small; 2023 Jun; 19(23):e2206929. PubMed ID: 36905239
[TBL] [Abstract][Full Text] [Related]
20. Drug releasing nanoplatforms activated by alternating magnetic fields.
Mertz D; Sandre O; Bégin-Colin S
Biochim Biophys Acta Gen Subj; 2017 Jun; 1861(6):1617-1641. PubMed ID: 28238734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
